Oral Nystatin is Safe During Breastfeeding
Oral nystatin is safe to use while breastfeeding, as it is poorly absorbed systemically and poses minimal risk to the nursing infant.
Key Evidence from FDA Labeling
The FDA drug label for oral nystatin states that "it is not known whether nystatin is excreted in human milk" but recommends caution when administered to nursing women 1. However, this conservative language reflects the lack of formal studies rather than evidence of harm.
Why Nystatin is Safe During Lactation
The pharmacokinetic properties of oral nystatin make it extremely unlikely to affect a breastfed infant:
- Nystatin is poorly absorbed from the gastrointestinal tract when taken orally 1
- With minimal systemic absorption in the mother, there is negligible transfer into breast milk
- Even if trace amounts entered breast milk, the infant would not absorb it systemically from their own GI tract
Clinical Practice Supports Use
Nystatin is commonly used in breastfeeding dyads for treating thrush:
- Oral nystatin for the infant combined with topical nystatin cream for the mother's breasts is the most common initial treatment approach for candidiasis in breastfeeding pairs 2
- This practice pattern among lactation experts demonstrates real-world confidence in its safety profile
Practical Recommendations
When prescribing oral nystatin to a breastfeeding mother:
- Continue breastfeeding without interruption - no need to pump and dump
- The medication can be used for standard treatment durations without concern
- Monitor the infant for any unusual symptoms (though adverse effects are not expected)
- Doses up to 5 million units daily have only caused maternal GI upset, with no serious toxic effects reported 1
The theoretical risk is extremely low, and the benefits of treating maternal oral candidiasis while maintaining breastfeeding far outweigh any minimal concerns.